ASBMT News  by unknown
ARMAND KEATING INSTALLED AS
ASBMT PRESIDENT; ROB NEGRIN
ELECTED VICE PRESIDENT
Armand Keating, MD, chief of med-
ical services at Princess Margaret Hos-
pital/Ontario Cancer Institute, has
been installed as president of the
American Society for Blood and Mar-
row Transplantation.
Robert S. Negrin, MD, associate
professor of medicine and director of
the Division of Bone Marrow Trans-
plantation at Stanford University, is
the newly elected vice president, to
become president in 2006.
Re-elected as secretary is Daniel J.
Weisdorf, MD, professor of medicine
at the University of Minnesota, direc-
tor of the University’s Adult Blood and
Marrow Transplant Program, and sci-
entific director for the National Mar-
row Donor Program.
New officers and directors were
chosen by mail ballot of the mem-
bers. Their installation was at the Tan-
dem BMT Meetings in February in Or-
lando. Newly elected and installed
directors are:
• Claudio Anasetti, MD, Fred Hutchin-
son Cancer Research Center, Seattle
• Samuel M. Silver, MD, PhD, Univer-
sity of Michigan, Ann Arbor
• Robert L. Truitt, PhD, Medical Col-
lege of Wisconsin Cancer Center,
Milwaukee
Nelson J. Chao, MD, professor of
medicine and director of the Division
of Hematology at Duke University
Medical Center, Durham, N. Carolina,
was elevated to president-elect and
will assume the presidency in 2005.
The new ASBMT president, Dr.
Keating, is director of the Division of
Hematology at the University of To-
ronto, and professor and head of the
Department of Medical Oncology
and Hematology, as well as chief of
medical services at Princess Margaret
Hospital/Ontario Cancer Institute. He
occupies the Gloria and Seymour Ep-
stein Chair in Cell Therapy and Trans-
plantation at the University of Toronto
and University Health Network.
Dr. Keating received his medical
degree cum laude in 1976 from the
University of Ottawa Medical School
and completed fellowships in internal
medicine and hematology at the Uni-
versity of Toronto. He is board certi-
fied in internal medicine. He was a
fellow in oncology at the Veterans
Administration Medical Center in Se-
attle and a post-doctoral fellow at the
Fred Hutchinson Cancer Research Cen-
ter in Seattle. He was a cancer research
scientist at the National Cancer Institute
of Canada from 1983 to 1993 and was
appointed first director of the Univer-
sity of Toronto Autologous Bone Mar-
row Transplant Program in 1986.
Dr. Keating is a founding member of
ASBMT and a counsellor for the Ameri-
can Society of Hematology (ASH) and
has chaired the Autologous Blood and
Marrow Transplant Registry (ABMTR).
He continues to serve on the execu-
tive committee of the IBMTR/ABMTR.
He is an associate editor of Biology of
Blood and Marrow Transplantation
and a co-editor of Bone Marrow
Transplantation. His research interests
include clinical and experimental he-
matopoietic cell transplantation and
the biology and clinical application of
marrow mesenchymal cells.
BBMT BEGINS WEB-BASED
MANUSCRIPT ACCEPTANCE
Biology of Blood and Marrow Trans-
plantation is now accepting manu-
scripts via the Web. Beginning in Feb-
ruary, manuscripts and related figures
and tables should be submitted elec-
tronically through the journal’s Web
site.
“I believe that authors will find the
new system very easy to handle, and
it provides us even greater speed in
the review process,” said Robert Korn-
gold, PhD, editor-in-chief.
Complete instructions are available
at the Web site, www.asbmt.org.
NEW INVESTIGATOR AWARDS
GO TO LDI AND GvL PROJECTS
Two recipients of new investigator
awards have been announced.
• Receiving the ASBMT/Fujisawa New
Investigator Award is Sijie Lu, PhD,
at M.D. Anderson Cancer Center.
His research proposal is entitled
“Selective Expansion of Anti-Leuke-
mic CTL for Donor Lymphocyte In-
fusion.”
• Receiving the ASBMT/ESP Pharma
New Investigator Award is Reddy
Pavan, MD, at the University of
Michigan. His research proposal is
entitled “Role of Antigen-Present-
ing Cells in Mediating Graft-versus-
Leukemia Effect After Experimental
Allogeneic Bone Marrow Trans-
plantation.”
The $25,000-per-year awards are
renewable for a second year.
“We had a spectacular group of
applications,” said ASBMT President
Joseph H. Antin, MD, who chaired
the committee that reviewed 29 re-
search proposals. “I extend my con-
gratulations, both personally and on
behalf of the Society, to these two
excellent scientists. I also wish to ex-
press my appreciation to both ESP
Pharma and Fujisawa for their gener-
ous support of these awards,” he
said.
2006 TANDEM BMT MEETINGS
TO CONVENE IN HONOLULU
Hotel and convention center nego-
tiations have been completed for the
2006 Tandem BMT Meetings that will
be held Feb. 15–19 in Honolulu.
The meetings will be at the Hawaii
Convention Center, with the Ala
Moana Hotel across the street as the
headquarters hotel. For those want-
ing to stay on Waikiki Beach, about
three blocks from the convention cen-
ter, guest rooms will also be available
at special group rates at the Renais-
sance Ilikai Waikiki Hotel and the
Hilton Hawaiian Village.
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